DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mookerjee RP, Mehta G, Balasubramaniyan V. , et al.
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.
J Hepatol 2015;
62 (02) 325-331
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.